CLINICAL_TRIALS
trial_result
· 2020-12-04
Clinical Trial Update: Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant [Phase 2]
Summary
Phase 2 trial update for Id-KLH vaccine combined with T cells in multiple myeloma patients undergoing transplant; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Pennsylvania | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2020-12-04